Detalhe da pesquisa
1.
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL).
Lancet
; 401(10370): 25-37, 2023 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36493791
2.
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE).
Lancet
; 401(10370): 38-48, 2023 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495881
3.
Patient research partner involvement in rheumatology research: a systematic literature review informing the 2023 updated EULAR recommendations for the involvement of patient research partners.
Ann Rheum Dis
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38724076
4.
Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis.
Ann Rheum Dis
; 83(6): 760-774, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503473
5.
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update.
Ann Rheum Dis
; 83(6): 706-719, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38499325
6.
Effect of Bimekizumab on Patient-Reported Disease Impact in Patients with Psoriatic Arthritis: 1-Year Results from Two Phase 3 Studies.
Rheumatology (Oxford)
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754125
7.
How do patient reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients.
Rheumatology (Oxford)
; 2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191998
8.
Psychometric properties of patient global assessment in Psoriatic Arthritis: a systematic literature review.
J Rheumatol
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359935
9.
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients.
Rheumatol Int
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597981
10.
Is the patient-perceived impact of psoriatic arthritis a global concept? An international study in 13 Arab countries (TACTIC study).
Rheumatol Int
; 44(5): 885-899, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498150
11.
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study.
Ann Rheum Dis
; 82(4): 496-506, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36600178
12.
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study.
Ann Rheum Dis
; 82(11): 1404-1414, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696588
13.
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis.
Ann Rheum Dis
; 82(9): 1162-1170, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295926
14.
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries.
Ann Rheum Dis
; 82(5): 698-709, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36787993
15.
Evaluation of the agreement between the ACR 1990 fibromyalgia tender points and an enthesitis score in patients with axial spondyloarthritis.
Rheumatology (Oxford)
; 62(8): 2757-2764, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36573318
16.
Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE.
Rheumatology (Oxford)
; 62(2): 617-628, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35789257
17.
Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis.
Rheumatology (Oxford)
; 62(2): 606-616, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35766811
18.
Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data.
Rheumatology (Oxford)
; 62(10): 3382-3390, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810788
19.
An international multi-centre analysis of current prescribing practices and shared decision-making in psoriatic arthritis.
Rheumatology (Oxford)
; 2023 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011669
20.
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status.
Rheumatology (Oxford)
; 62(4): 1621-1626, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124987